Edwards Lifesciences Corp
Edwards Lifesciences Corp/ US28176E1082 /
EW
|
11/29/2023 9:59:59 PM
|
Chg.
+0.33
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
67.43USD
|
+0.49%
|
147,446
Turnover: 9.96 mill. |
-Bid Size: - |
-Ask Size: - |
40.9 bill.USD |
- |
27.41 |
Fundamentals
| |
FY 2022 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
2.46 USD |
2.07% |
| EPS Diluted: |
2.44 USD |
2.52% |
| Revenues per Share: |
8.85 USD |
5.38% |
| Book Value per Share: |
9.55 USD |
1.94% |
| Cash Flow per Share: |
2.00 USD |
-27.95% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
5,382.40 USD |
2.86% |
| Net Income: |
1,521.90 USD |
1.25% |
| Operating Cash Flow: |
1,218.20 USD |
- |
| Cash and Cash Equivalents: |
769.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
27.41 |
30.33 |
| P/S Ratio: |
7.62 |
8.43 |
| P/BV ratio: |
7.06 |
7.82 |
| P/CF Ratio: |
33.67 |
37.26 |
| PEG: |
13.21 |
14.62 |
| Earnings Yield: |
3.65% |
3.30% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
40.9 bill. USD |
45.39 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
606.5 mill. |
|
Profitability
| Gross Profit Margin: |
79.93% |
| EBIT Margin: |
32.49% |
| Net Profit Margin: |
28.28% |
| Return on Equity: |
26.21% |
| Return on Assets: |
18.35% |
Financial Strength
| Liquidity I / Cash Ratio: |
75.22% |
| Liquidity II / Quick Ratio: |
138.11% |
| Liquidity III / Current Ratio: |
302.80% |
| Debt / Equity Ratio: |
42.81% |
| Dynam. Debt / Equity Ratio: |
204.06% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
12/31/2022 |
| Accounting Standard: |
US GAAP |